Physician network position and patient outcomes following implantable cardioverter defibrillator therapy

被引:8
作者
Moen, Erika L. [1 ,2 ]
Bynum, Julie P. [3 ]
Skinner, Jonathan S. [4 ,5 ]
O'Malley, Alistair J. [1 ,2 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH 03756 USA
[2] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA
[4] Dept Econ, Hanover, NH USA
[5] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA
关键词
case fatality; degree centrality; implantable cardioverter defibrillator; physician network; OPERATIVE MORTALITY; HOSPITAL VOLUME; SHARING NETWORKS; SEX-DIFFERENCES; SURGEON VOLUME; COMPLICATIONS;
D O I
10.1111/1475-6773.13151
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective To evaluate two novel measures of physician network centrality and their associations with implantable cardioverter defibrillator (ICD) procedure volume and health outcomes. Data Sources Medicare claims and the National Cardiovascular Data Registry data from 2007 to 2011. Study Design We constructed a national cardiovascular disease patient-sharing physician network and used network analysis to characterize physician network centrality with two measures: within-hospital degree centrality (number of connections within a hospital) and across-hospital degree centrality (number of connections across hospitals). The primary outcome was risk-adjusted 2-year case fatality. Hierarchical logistic regression estimated the effects of physician's within-hospital and across-hospital degree centrality on case fatality. We included 105 109 ICD therapy patients and 3474 ICD implanting physicians in our analyses. Principal Findings After controlling for other physician and hospital characteristics, we observed greater risk-adjusted case fatality among patients treated by physicians in the highest across-hospital degree tertile compared to lowest tertile (OR [95% CI] = 1.10 [1.04-1.16], P = 0.001) and lowest tertile volume physicians compared with highest volume (OR [95% CI] = 0.90 [0.84-0.95], P < 0.001). Physician's within-hospital degree tertile was inversely associated with case fatality but not statistically significant. Conclusions Degree centrality measures capture information independent of procedure volume and raise questions about the quality of physicians with networks that predict worse health outcomes.
引用
收藏
页码:880 / 889
页数:10
相关论文
共 50 条
  • [21] Athletic participation in the young patient with an implantable cardioverter-defibrillator
    Lampert, Rachel
    Law, Ian
    CARDIOLOGY IN THE YOUNG, 2017, 27 : S132 - S137
  • [22] The implantable cardioverter-defibrillator: patient care and quality of life
    Wellens, H. J.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07): : 364 - 365
  • [23] Anaesthetic management of a patient with an automatic implantable cardioverter defibrillator in situ
    Kam, PCA
    BRITISH JOURNAL OF ANAESTHESIA, 1997, 78 (01) : 102 - 106
  • [24] Follow-up of the patient with automatic implantable cardioverter defibrillator
    Cruz Cardentey, Marleny
    Prieto Guerra, Maidelis
    Gutierrez Lopez, Alain
    Mengana Betancourt, Ana
    Ramos Cordero, Michel Y.
    Tannis Wilson, Eko
    Tamargo Barbeito, Teddy O.
    CORSALUD, 2020, 12 (03): : 283 - 291
  • [25] Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention Cohort
    van Barreveld, Marit
    Verstraelen, Tom E.
    van Dessel, Pascal F. H. M.
    Boersma, Lucas V. A.
    Delnoy, Peter Paul H. M.
    Tuinenburg, Anton E.
    Theuns, Dominic A. M. J.
    van der Voort, Pepijn H.
    Kimman, Geert-Jan
    Buskens, Erik
    Zwinderman, Aeilko H.
    Wilde, Arthur A. M.
    Dijkgraaf, Marcel G. W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (07):
  • [26] COMPLICATIONS OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY - FOLLOW-UP OF 241 PATIENTS
    GRIMM, W
    FLORES, BF
    MARCHLINSKI, FE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (01): : 218 - 222
  • [27] Management of patients following implantable cardioverter-defibrillator therapy-The importance of a multifaceted approach
    Selvarajah, Karshana
    Khan, Parisha
    Jahagirdar, Nishat
    Cannata, Antonio
    Mukherjee, Rahul
    Bromage, Daniel I.
    Mcdonagh, Theresa
    Murgatroyd, Francis
    Scott, Paul A.
    JOURNAL OF ARRHYTHMIA, 2025, 41 (01)
  • [28] Inappropriate therapy due to triple counting of the ventricular electrogram in a patient with implantable cardioverter-defibrillator
    Alasti, M
    Haghjoo, M
    Alizadeh, A
    Fazelifar, AF
    Sadr-Ameli, MA
    HEART RHYTHM, 2005, 2 (11) : 1253 - 1255
  • [29] Implantable Cardioverter Defibrillator Therapy in Children with Long QT Syndrome
    A. K. Goel
    S. Berger
    A. Pelech
    A. Dhala
    Pediatric Cardiology, 2004, 25 : 370 - 378
  • [30] Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT
    Poole, Jeanne E.
    Olshansky, Brian
    Mark, Daniel B.
    Anderson, Jill
    Johnson, George
    Hellkamp, Anne S.
    Davidson-Ray, Linda
    Fishbein, Daniel P.
    Boineau, Robin E.
    Anstrom, Kevin J.
    Reinhall, Per G.
    Packer, Douglas L.
    Lee, Kerry L.
    Bardy, Gust H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (04) : 405 - 415